BlackRock Institutional Trust Company, N.A. - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 159 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.27 and the average weighting 0.5%.

Quarter-by-quarter ownership
BlackRock Institutional Trust Company, N.A. ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$50,598,000
+4.6%
497,965
+5.0%
0.01%
-12.5%
Q3 2016$48,390,000
-18.7%
474,130
-5.0%
0.01%
-20.0%
Q2 2016$59,553,000
+17.4%
499,312
+5.4%
0.01%
+25.0%
Q1 2016$50,712,000
-1.2%
473,544
+0.0%
0.01%0.0%
Q4 2015$51,330,000
+26.3%
473,441
-0.3%
0.01%
+14.3%
Q3 2015$40,657,000
-22.1%
474,691
-8.2%
0.01%
-12.5%
Q2 2015$52,200,000
+18.5%
517,342
-9.4%
0.01%
+14.3%
Q1 2015$44,037,000
+42.5%
571,094
-1.6%
0.01%
+40.0%
Q4 2014$30,897,000
+20.2%
580,662
+6.2%
0.01%
+25.0%
Q3 2014$25,696,000
-30.4%
546,847
-7.8%
0.00%
-33.3%
Q2 2014$36,944,000
-3.9%
593,089
+3.8%
0.01%
-14.3%
Q1 2014$38,430,000
+33.3%
571,286
+4.2%
0.01%
+40.0%
Q4 2013$28,831,000
+16.4%
548,110
-4.2%
0.01%0.0%
Q3 2013$24,771,000
-1.4%
572,344
-14.8%
0.01%0.0%
Q2 2013$25,128,000671,8740.01%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
BVF INC/IL 2,626,160$138,136,00024.17%
KNOTT DAVID M 1,292,566$67,988,972,00013.87%
GROW Partners, LLC 200,000$10,520,0006.41%
Opaleye Management Inc. 90,000$4,860,000,0003.82%
OBERWEIS ASSET MANAGEMENT INC/ 213,317$11,220,0002.72%
First Light Asset Management, LLC 60,242$3,169,0002.69%
Timpani Capital Management LLC 98,956$5,205,0002.59%
Iguana Healthcare Management, LLC 75,000$3,945,0002.25%
Eventide Asset Management 134,400$7,069,0002.18%
ASHFORD CAPITAL MANAGEMENT INC 215,223$11,321,0002.16%
View complete list of LIGAND PHARMACEUTICALS INC shareholders